0 Commenti
0 condivisioni
314 Views
0 Anteprima
Cerca
Scopri nuove persone e i loro amici a quattro zampe, e fai nuove amicizie
-
Effettua l'accesso per mettere mi piace, condividere e commentare!
-
Rising Demand for Maternal Health Supplements in Saudi Arabia – Market Insights 2025–2032The Saudi Arabia Maternal Supplements Market is projected to witness significant growth, driven by rising awareness of maternal health and nutritional needs. With a forecasted CAGR of around 5.65% from 2025 to 2032, the market size was valued at approximately USD 78 million in 2023, reflecting extensive consumer demand and evolving healthcare initiatives. Saudi Arabia Maternal Supplements...0 Commenti 0 condivisioni 331 Views 0 Anteprima
-
Women’s Health and Beauty Supplements Market: Growth Dynamics, Trends, and Future OutlookThe Women’s Health and Beauty Supplements Market has grown rapidly in recent years as women increasingly prioritize wellness, preventive care, and holistic beauty solutions. These supplements are designed to support overall health while enhancing skin, hair, nails, hormonal balance, immunity, and energy levels. Rising health awareness, busy lifestyles, and the influence of digital...0 Commenti 0 condivisioni 19 Views 0 Anteprima
-
Altapharma Market Expected to Soar to $4.37 Billion by 2032Introspective Market Research (IMR) today released its in-depth report on the Global Altapharma Market, forecasting robust expansion over the next decade. According to the report, the market was valued at USD 2.30 billion in 2023 and is expected to grow to USD 4.37 billion by 2032, representing a compound annual growth rate (CAGR) of 7.40% during 2024–2032. The surge in altapharma...0 Commenti 0 condivisioni 44 Views 0 Anteprima
-
Altapharma Market Expected to Soar to $4.37 Billion by 2032Introspective Market Research (IMR) today released its in-depth report on the Global Altapharma Market, forecasting robust expansion over the next decade. According to the report, the market was valued at USD 2.30 billion in 2023 and is expected to grow to USD 4.37 billion by 2032, representing a compound annual growth rate (CAGR) of 7.40% during 2024–2032. The surge in altapharma...0 Commenti 0 condivisioni 38 Views 0 Anteprima